National Heart, Lung, and Blood Institute; Notice of Meeting, 40073-40074 [2018-17341]

Download as PDF Federal Register / Vol. 83, No. 156 / Monday, August 13, 2018 / Notices Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Imperial Hotel RaleighDurham, 4700 Emperor Boulevard, Durham, NC 27709. Contact Person: Linda K. Bass, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, National Institute of Environmental Health Sciences Research, Triangle Park, NC 27709, 919–541–1307, bass@niehs.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: August 7, 2018. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–17343 Filed 8–10–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request Collection of Customer Service, Demographic, and Smoking/Tobacco Use Information From the National Cancer Institute’s Contact Center (CC) Clients (NCI); Correction AGENCY: National Institutes of Health, HHS. ACTION: Notice; correction. The Department of Health and Human Services, National Institutes of Health published a Notice in the Federal Register on July 27, 2018. That Notice inadvertently contained an error in the Estimated Annualized Burden Hours Table. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Mary Anne Bright, Supervisory Public Health Advisor, CCPIB/OCPL, 9609 Medical Center Drive, Rockville, MD 20850, or call nontoll-free number 240–276–6647 or Email your request, including your address to: brightma@mail.nih.gov. SUPPLEMENTARY INFORMATION: On July 27, 2018, the Department of Health and Human Services, National Institutes of sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 20:42 Aug 10, 2018 Jkt 244001 Health published a Notice in the Federal Register on page 35669 (83 FR 35668) that inadvertently contained an error Table A. 12–1—Estimate of Annual Burden Hours. The purpose of this notice is to correct Table A. 12–1— Total Estimate of Annual Burden Hours from 1875 to 1865. Dated: August 7, 2018. Karla C. Bailey, Project Clearance Liaison, National Cancer Institute, National Institutes of Health. [FR Doc. 2018–17344 Filed 8–10–18; 8:45 am] BILLING CODE 4140–01–P 40073 Contact Person: Priti Mehrotra, Ph.D., Chief, Immunology Review Branch, Scientific Review Program, Division of Extramural Activities, Room #3G40, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892–7616, 240–669– 5066, pmehrotra@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 7, 2018. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–17342 Filed 8–10–18; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–P National Institutes of Health DEPARTMENT OF HEALTH AND National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings HUMAN SERVICES National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIH; Support for Conferences and Scientific Meetings (R13). Date: August 22–24, 2018. Time: 9:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Virtual Meeting). Contact Person: Tracy A. Shahan, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room #3F31, National Institutes of Health/ NIAID, 5601 Fishers Lane, MSC 9834, Bethesda, MD 20892–9834, (240) 669–5030, tshahan@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID; Investigator-Initiated Clinical Trial Planning Grant (R34). Date: August 27, 2018. Time: 9:30 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Heart, Lung, and Blood Advisory Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Heart, Lung, and Blood Advisory Council. Date: September 5, 2018. Open: 8:00 a.m. to 1:30 p.m. Agenda: To discuss program policies and issues. Place: National Institutes of Health, Building 35A, Porter Building, Room 640, 35A Convent Drive, Bethesda, MD 20892. Open: 2:30 p.m. to 3:00 p.m. Agenda: To discuss program policies and issues. Place: National Institutes of Health, Building 35A, Porter Building, Room 640, 35A Convent Drive, Bethesda, MD 20892. Contact Person: Laura K. Moen, Ph.D., Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7100, Bethesda, MD 20892, 301–435–0260, moenl@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, E:\FR\FM\13AUN1.SGM 13AUN1 40074 Federal Register / Vol. 83, No. 156 / Monday, August 13, 2018 / Notices including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: www.nhlbi.nih.gov/meetings/nhlbac/ index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: August 8, 2018. David D. Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–17341 Filed 8–10–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Accreditation and Approval of SGS North America, Inc., as a Commercial Gauger and Laboratory U.S. Customs and Border Protection, Department of Homeland Security. ACTION: Notice of accreditation and approval of SGS North America, Inc., as a commercial gauger and laboratory. AGENCY: Notice is hereby given, pursuant to CBP regulations, that SGS North America, Inc., has been approved to gauge and accredited to test petroleum and petroleum products for customs purposes for the next three years as of March 2, 2018. DATES: The accreditation and approval of SGS North America, Inc., as commercial gauger and laboratory became effective on March 2, 2018. The next triennial inspection date will be scheduled for March 2021. FOR FURTHER INFORMATION CONTACT: Mr. Stephen Cassata, Laboratories and Scientific Services, U.S. Customs and Border Protection, 1300 Pennsylvania Avenue NW, Suite 1500N, Washington, DC 20229, tel. 202–344–1060. SUMMARY: Notice is hereby given pursuant to 19 CFR 151.12 and 19 CFR 151.13, that SGS North America, Inc., 7315 S. 76th Ave., Bridgeview, IL 60455, has been approved to gauge and accredited to test petroleum and petroleum products for customs purposes, in accordance with the provisions of 19 CFR 151.12 and 19 CFR 151.13. SGS North America, Inc., is approved for the following gauging procedures for petroleum and certain petroleum products set forth by the American Petroleum Institute (API): SUPPLEMENTARY INFORMATION: API chapters 1 ..................... 3 ..................... 7 ..................... 8 ..................... 9 ..................... 12 ................... 17 ................... Title Vocabulary. Tank gauging. Temperature Determination. Sampling. Density Determinations. Calculations. Maritime Measurements. SGS North America, Inc., is accredited for the following laboratory analysis procedures and methods for petroleum and certain petroleum products set forth by the U.S. Customs and Border Protection Laboratory Methods (CBPL) and American Society for Testing and Materials (ASTM): ASTM Title 27–08 ................................... 27–11 ................................... ASTM D–86 ........................ ASTM D–445 ...................... 27–13 ................................... ASTM D–4294 .................... 27–48 ................................... ASTM D–4052 .................... 27–50 ................................... 27–53 ................................... ASTM D–93 ........................ ASTM D–2709 .................... 27–58 ................................... N/A ....................................... ASTM D–5191 .................... ASTM D–1319 .................... N/A ....................................... ASTM D–3606 .................... N/A ....................................... ASTM D–4815 .................... N/A ....................................... sradovich on DSK3GMQ082PROD with NOTICES CBPL No. ASTM D–5453 .................... Standard Test Method for Distillation of Petroleum Products. Standard test method for kinematic viscosity of transparent and opaque liquids (and calculations of dynamic viscosity). Standard test method for sulfur in petroleum and petroleum products by energy-dispersive x-ray fluorescence spectrometry. Standard test method for density and relative density of liquids by digital density meter. Standard Test Methods for Flash-Point by Pensky-Martens Closed Cup Tester. Standard Test Method for Water and Sediment in Middle Distillate Fuels by Centrifuge. Standard Test Method For Vapor Pressure of Petroleum Products (Mini Method). Standard Test Method for Hydrocarbon Types in Liquid Petroleum Products by Fluorescent Indicator Adsorption. Standard Test Method for Determination of Benzene and Toluene in Finished Motor and Aviation Gasoline by Gas Chromatography. Standard Test Method for Determination of MTBE, ETBE, TAME, DIPE, tertiaryAmyl Alcohol and C1 to C4 Alcohols in Gasoline by Gas Chromatography. Standard Test Method for Determination of Total Sulfur in Light Hydrocarbons, Spark Ignition Engine Fuel, Diesel Engine Fuel, and Engine Oil by Ultraviolet Fluorescence. Anyone wishing to employ this entity to conduct laboratory analyses and gauger services should request and receive written assurances from the entity that it is accredited or approved by the U.S. Customs and Border Protection to conduct the specific test or gauger service requested. Alternatively, inquiries regarding the specific test or gauger service this entity is accredited or approved to perform may be directed VerDate Sep<11>2014 20:42 Aug 10, 2018 Jkt 244001 to the U.S. Customs and Border Protection by calling (202) 344–1060. The inquiry may also be sent to cbp.labhq@dhs.gov. Please reference the website listed below for a complete listing of CBP approved gaugers and accredited laboratories: https:// www.cbp.gov/about/labs-scientific/ commercial-gaugers-and-laboratories. PO 00000 Frm 00094 Fmt 4703 Sfmt 9990 Dated: August 2, 2018. Dave Fluty, Executive Director, Laboratories and Scientific Services Directorate. [FR Doc. 2018–17236 Filed 8–10–18; 8:45 am] BILLING CODE 9111–14–P E:\FR\FM\13AUN1.SGM 13AUN1

Agencies

  • DEPARTMENT OF HEALTH AND
[Federal Register Volume 83, Number 156 (Monday, August 13, 2018)]
[Notices]
[Pages 40073-40074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17341]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND

HUMAN SERVICES National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Heart, 
Lung, and Blood Advisory Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations should notify the Contact Person listed 
below in advance of the meeting.

    Name of Committee: National Heart, Lung, and Blood Advisory 
Council.
    Date: September 5, 2018.
    Open: 8:00 a.m. to 1:30 p.m.
    Agenda: To discuss program policies and issues.
    Place: National Institutes of Health, Building 35A, Porter 
Building, Room 640, 35A Convent Drive, Bethesda, MD 20892.
    Open: 2:30 p.m. to 3:00 p.m.
    Agenda: To discuss program policies and issues.
    Place: National Institutes of Health, Building 35A, Porter 
Building, Room 640, 35A Convent Drive, Bethesda, MD 20892.
    Contact Person: Laura K. Moen, Ph.D., Director, Division of 
Extramural Research Activities, National Heart, Lung, and Blood 
Institute, National Institutes of Health, 6701 Rockledge Drive, Room 
7100, Bethesda, MD 20892, 301-435-0260, [email protected].
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles,

[[Page 40074]]

including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: www.nhlbi.nih.gov/meetings/nhlbac/index.htm, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)


    Dated: August 8, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-17341 Filed 8-10-18; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.